Anti-counterfeit Pharmaceutical Packaging Market - Global Industry Analysis

Table Of Content

Methodology

Free Analysis

Counterfeits or making duplicate devices are illicit reproductions of a trademarked brand which are identical to genuine products. Those counterfeit goods contain clothing, medications and pharmaceutical products, electronics, and jewelry among others. In order to counter infringement, secure packaging is necessary. Secure and safe packaging in case of medicinal and other pharmaceutical products is one of the crucial techniques to keep these products away from counterfeiting. Anti-counterfeit packaging is the next level or method of secure packaging to the product in order to diminish infringement. In the process of anti-counterfeit packaging, secure packaging is implemented that prevents duplication and assures the safety and security of the medicinal goods. Anti-counterfeit measurements are adopted by organizations with the collaboration of government in developed as well as developing nations, in order to counterfeit not only in terms of goods and products but also in terms of revenue and brand value loyalty. 

Anti-counterfeit pharmaceutical packaging is experiencing the highest growth rate for waste streams in developed as well as developing countries. Rising health awareness among the people across the globe is the main factor that is fueling the growth of the market. Medicinal and pharmaceutical products are regarded as one of the basic needs of consumer whenever they are facing some serious health issue. According to OECD (Organization for Economic Co-operation and Development), about 10% of the pharmaceutical products are counterfeit. This imitation or duplication of medical products happens in the supply chain or distribution of any organization. For this reason, the counterfeiting of the products is very difficult to counter and regulate. In addition, duplicate medicines affect the reputation of the pharmaceutical organizations along with the patient's health. Thus, organizations across the globe are adopting various technologies in order to counter the infringement of the medicinal devices. In order to retain the brand loyalty and brand image in the minds of consumers, organizations are heavily investing in R&D activities in order to come up with the secure packaging of pharmaceutical products. Such factors are contributing towards the market growth and development during the forecast time period. 

 
Based on the usage, the anti-counterfeit pharmaceutical packaging market is categorized into covert features, forensic markers, overt features, tamper evidence, track & trace technologies. Trace and track technologies can be bifurcated into serialization and identification. On the basis of technology, the market is segmented into RFID, security printing and graphics, security ink coatings, mass encoding, and holograms. RFID is divided into active tags, semi-active tags, and passive tags. Mass encoding can further be segmented into barcode application, digital mass encryption, and others (electronic surveillance technologies). 
 
North America held noteworthy revenue share of the global anti-counterfeit pharmaceutical packaging market in 2017 and the region is expected to continue with its regional superiority over the forecast period. The growth of this regional market is attributed because of the stringent regulations formulated by the government coupled with FDA. In addition, the region is the major biologics research hub, which exports medical and pharmaceutical products across the globe. Such factors are contributing to the growth of the market in the region. The Asia Pacific is predicted to provide significant opportunities for anti-counterfeit pharmaceutical packaging. The growth of the region is anticipated due to raising awareness among the consumers and manufacturers regarding infringement. Moreover, the rising trend towards social and healthcare system in the regions is fueling the growth of the market. Such factors are expected to drive anti-counterfeit pharmaceutical packaging market growth in the Asia Pacific region over the forecast timeframe. 
 
Some of the industry players operating in the anti-counterfeit pharmaceutical packaging market include Zebra Technologies Corporation, Dennison Corporation, E.I. du Pont de Nemours and Company, AlpVision SA, Sicpa Holding SA, Applied DNA Sciences Inc., Amcor Limited, Authentix Inc., CCL Industries Inc., and Atlantic Zeiser GmbH.